title: Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies.
abstract: A research project involving sheets of retinal pigment epithelium constructed from iPS cells derived from patients with age-related maculopathy is one step closer to being approved for clinical trials by the Japanese Government. Now is the time to make therapies using iPS cells clinically available.
authors.affiliation: Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
authors.forename: Peipei
authors.initials: P
authors.lastname: Song
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Inagaki
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Sugawara
authors.forename: Norihiro
authors.initials: N
authors.lastname: Kokudo
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology* / Q000502:physiology; D007564:Japan; D008268:Macular Degeneration / Q000628:therapy*; D055213:Retinal Pigment Epithelium / Q000166:cytology